| Literature DB >> 31801888 |
Dan Z Milikovsky1, Jonathan Ofer1, Vladimir V Senatorov2,3,4, Aaron R Friedman3, Ofer Prager1, Liron Sheintuch1, Netta Elazari1, Ronel Veksler1, Daniel Zelig1, Itai Weissberg1, Guy Bar-Klein5, Evyatar Swissa1, Erez Hanael6, Gal Ben-Arie7, Osnat Schefenbauer1, Lyna Kamintsky8, Rotem Saar-Ashkenazy1,9, Ilan Shelef7, Merav H Shamir6, Ilan Goldberg10, Amir Glik11,12,13, Felix Benninger11,13, Daniela Kaufer2,3, Alon Friedman14,8.
Abstract
A growing body of evidence shows that epileptic activity is frequent but often undiagnosed in patients with Alzheimer's disease (AD) and has major therapeutic implications. Here, we analyzed electroencephalogram (EEG) data from patients with AD and found an EEG signature of transient slowing of the cortical network that we termed paroxysmal slow wave events (PSWEs). The occurrence per minute of the PSWEs was correlated with level of cognitive impairment. Interictal (between seizures) PSWEs were also found in patients with epilepsy, localized to cortical regions displaying blood-brain barrier (BBB) dysfunction, and in three rodent models with BBB pathology: aged mice, young 5x familial AD model, and status epilepticus-induced epilepsy in young rats. To investigate the potential causative role of BBB dysfunction in network modifications underlying PSWEs, we infused the serum protein albumin directly into the cerebral ventricles of naïve young rats. Infusion of albumin, but not artificial cerebrospinal fluid control, resulted in high incidence of PSWEs. Our results identify PSWEs as an EEG manifestation of nonconvulsive seizures in patients with AD and suggest BBB pathology as an underlying mechanism and as a promising therapeutic target.Entities:
Year: 2019 PMID: 31801888 DOI: 10.1126/scitranslmed.aaw8954
Source DB: PubMed Journal: Sci Transl Med ISSN: 1946-6234 Impact factor: 17.956